# OnCo record vismoneo (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/vismoneo/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "vismoneo", "NCT02667574" ;
  schema:name "VISMONEO (vismodegib before surgery for locally advanced basal cell carcinoma)"@en ;
  schema:alternateName "VISMONEO"@en ;
  schema:description "Giving the hedgehog pill first to shrink a large facial basal cell carcinoma made the operation smaller or less disfiguring in four out of five people. Over three years, though, more than a third of those who benefited had the cancer back."@en ;
  schema:url <https://onco.cc/trials/vismoneo/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02667574>, <https://doi.org/10.1016/j.eclinm.2021.100844>, <https://pubmed.ncbi.nlm.nih.gov/33997740/> ;
  onco:status "positive" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/basal-cell-carcinoma/>, <https://onco.cc/cancers/locally-advanced-bcc/>, <https://onco.cc/cancers/skin-cancer/> ;
  onco:technologies <https://onco.cc/technologies/hedgehog-inhibitors/> ;
  onco:targets <https://onco.cc/targets/smoothened/> ;
  onco:drugs <https://onco.cc/drugs/vismodegib/> ;
  onco:companies <https://onco.cc/companies/roche-genentech/> ;
  onco:pathways <https://onco.cc/pathways/hedgehog/> ;
  onco:terms <https://onco.cc/terms/hedgehog-inhibitor-tolerability/>, <https://onco.cc/terms/mohs-surgery/> ;
  onco:trials <https://onco.cc/trials/erivance/>, <https://onco.cc/trials/stevie/>, <https://onco.cc/trials/cemiplimab-advanced-bcc/> .